Financing, Equity Capital Markets
Capricor Therapeutics, Inc.
10/24
|
$75.0 Million
Âé¶¹´«Ã½ served as bookrunner for Capricor Therapeutics, Inc. on its CMFO
Sub-Type
CMFO
Sector
Sub-Sector
Biopharma